Cargando…

HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells

BACKGROUND: Little is known about the relationship between N6-methyladenosine (m6A)-related genes and tumor immune microenvironment (TIME) in non-small cell lung cancer (NSCLC). It is unclear which m6A regulators are essential for NSCLC progression. The aim of this work was to excavate the role of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Zhuoyu, Yang, Yang, Ma, Qian, Wang, Hui, Zhao, Song, Qi, Yu, Li, Yixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761959/ https://www.ncbi.nlm.nih.gov/pubmed/36536402 http://dx.doi.org/10.1186/s12931-022-02227-y

Ejemplares similares

HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT
por: Huang, Guang-Zhao, et al.
Publicado: (2020)

Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response
por: Wu, Yusheng, et al.
Publicado: (2018)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3
por: Yang, Nannan, et al.
Publicado: (2022)

Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC
por: Xiang, Zijin, et al.
Publicado: (2022)

hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles
por: Fischl, Harry, et al.
Publicado: (2019)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
por: Zheng, Jingyi, et al.
Publicado: (2023)

5-HT(7) Receptor Contributes to Proliferation, Migration and Invasion in NSCLC Cells
por: Du, Xiaohui, et al.
Publicado: (2020)

hnRNPC induces isoform shifts in miR-21-5p leading to cancer development
por: Park, Seokju, et al.
Publicado: (2022)

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson's Disease
por: Quan, Wei, et al.
Publicado: (2021)

Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC
por: Zhang, Zhimin, et al.
Publicado: (2021)

The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma
por: Li, Yixin, et al.
Publicado: (2022)

Overexpression of hnRNPC2 induces multinucleation by repression of Aurora B in hepatocellular carcinoma cells
por: SUN, DA-QUAN, et al.
Publicado: (2013)

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
por: Li, Yixin, et al.
Publicado: (2022)

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
por: Grenda, Anna, et al.
Publicado: (2021)

Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC
por: Wang, Zemin, et al.
Publicado: (2022)

Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification
por: Zhang, Yu, et al.
Publicado: (2017)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
por: Herzner, Anna-Maria, et al.
Publicado: (2021)

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
por: Ding, Wenjing, et al.
Publicado: (2023)

LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC
por: Cai, Yunshi, et al.
Publicado: (2022)

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
por: Schneider, Marc A., et al.
Publicado: (2022)

Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma
por: Ma, Yibo, et al.
Publicado: (2022)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
por: Ma, Chao, et al.
Publicado: (2023)

HNRNPC regulates RhoA to induce DNA damage repair and cancer‐associated fibroblast activation causing radiation resistance in pancreatic cancer
por: Xia, Ning, et al.
Publicado: (2022)

MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
por: Cheng, Zhenshun, et al.
Publicado: (2014)

LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2
por: He, Qiuming, et al.
Publicado: (2022)

Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
por: Zarogoulidis, Paul, et al.
Publicado: (2020)

Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification
por: Zhang, Yu, et al.
Publicado: (2022)

MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells
por: Kleemann, Michael, et al.
Publicado: (2018)

Essential m(6)A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma
por: Wu, Jiajin, et al.
Publicado: (2022)

HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression
por: Liu, Danfei, et al.
Publicado: (2022)

Current status and challenges of immunotherapy in ALK rearranged NSCLC
por: Qi, Rongbin, et al.
Publicado: (2022)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Immunotherapy in NSCLC Patients with Brain Metastases
por: Buriolla, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ouk90fdfkgae150ltl20l6eav